2021

BIOHARVEST SCIENCES INC. REPORTS STRONG Q3 2021 RESULTS ON ALL OF THE COMPANY’S ACTIVITIES

44% quarter over quarter sales growth with record VINIA® sales orders of USD 688K in Q3 Successful VINIA® pilot sales program in the U.S. market with USD 236K in sales orders in Q3  Major progress towards the commissioning of the 20Tons/year VINIA® new production facility before year end Significant accomplishments in cannabis development program; commercialisation on

BIOHARVEST SCIENCES INC. REPORTS STRONG Q3 2021 RESULTS ON ALL OF THE COMPANY’S ACTIVITIES Read More »

BIOHARVEST SCIENCES INC ANNOUNCES THE CLOSING OF ITS PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT AND THE AMOUNT RAISED FROM EXERCISE OF WARRANTS

Total of CAD$ 7,909,064 raised from private placement and warrants exercised   VANCOUVER, CANADA, and REHOVOT, ISRAEL, October 4, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces the closing of its second and final tranche of the private placement announced on August 4th, 2021. Under this private placement, the Company issued a

BIOHARVEST SCIENCES INC ANNOUNCES THE CLOSING OF ITS PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT AND THE AMOUNT RAISED FROM EXERCISE OF WARRANTS Read More »

BIOHARVEST SCIENCES NEW 20 TONS PER YEAR FACTORY SUCCESSFULLY PASSES THE ISO9001 AND ISO22000 (HACCP) AUDIT

Milestone achieved towards the imminent commissioning of the new factory, which will meet the increased demand for VINIA® On track for the conversion of the existing 2 tons/year facility to a Cannabis production facility within H1, 2022 VANCOUVER, CANADA, and REHOVOT, ISRAEL, September 9, 2021 – BioHarvest Sciences Inc.(“BioHarvest” or the “Company”) (CSE: BHSC) announces that

BIOHARVEST SCIENCES NEW 20 TONS PER YEAR FACTORY SUCCESSFULLY PASSES THE ISO9001 AND ISO22000 (HACCP) AUDIT Read More »

BIOHARVEST SCIENCES INC. SUCCESSFULLY DELIVERS A MAJOR MILESTONE IN THE SCALE-UP PROCESS OF ITS CANNABIS DEVELOPMENT PROGRAM

The Company is now growing Cannabis cells with trichomes in medium-scale bioreactors representing a 250x increase in scale On track for commercialization of Cannabis & Hemp based products in H1-2022 VANCOUVER, CANADA, and REHOVOT, ISRAEL, September 1, 2021 – BioHarvest Sciences Inc.(“BioHarvest” or the “Company”) (CSE: BHSC) is announcing today that it has successfully scaled its

BIOHARVEST SCIENCES INC. SUCCESSFULLY DELIVERS A MAJOR MILESTONE IN THE SCALE-UP PROCESS OF ITS CANNABIS DEVELOPMENT PROGRAM Read More »

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF ITS PRIVATE PLACEMENT

First tranche closed represents over three-quarters of the anticipated financing.  VANCOUVER, CANADA, and REHOVOT, ISRAEL, August 30, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) is pleased to announce that it has closed the first tranche (the “First Tranche”) of its non-brokered private placement (the “Private Placement”) previously announced on August 4, 2021.

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF ITS PRIVATE PLACEMENT Read More »